Rubraca
Analogs of Rubraca
Find cheaper analogs and generic equivalents for Rubraca.
Active Ingredient: rucaparib camsylate
Product Overview
About Rubraca
Rubraca is a prescription medicine that should be started and supervised by a doctor who has experience in the treatment of cancer.
What it is used for
Not available in this source.
How it is used
Rubraca is available as tablets to be taken twice a day. Treatment should continue until the cancer progresses or the patient has unacceptable side effects, and no longer than 2 years for patients newly diagnosed with advanced cancer. Treatment with Rubraca should be started no later than 8 weeks after the patient has finished their treatment with platinum-based chemotherapy.
How it works
The active substance in Rubraca, rucaparib, blocks the activity of a family of proteins called poly(ADP-ribose) polymerases (PARPs) that help to repair damaged DNA in cells (both normal and cancer cells). When PARP proteins are blocked, the damaged DNA in the cancer cells cannot be repaired and the cells die as a result.
Active substance: rucaparib
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
